Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 27

1.

Treatment of infants with lymphoblastic leukaemia: results of the UK Infant Protocols 1987-1999.

Chessells JM, Harrison CJ, Watson SL, Vora AJ, Richards SM; Medical Research Council Working Party on Childhood Leukaemia.

Br J Haematol. 2002 May;117(2):306-14.

PMID:
11972512
2.

Childhood acute lymphoblastic leukemia with the MLL-ENL fusion and t(11;19)(q23;p13.3) translocation.

Rubnitz JE, Camitta BM, Mahmoud H, Raimondi SC, Carroll AJ, Borowitz MJ, Shuster JJ, Link MP, Pullen DJ, Downing JR, Behm FG, Pui CH.

J Clin Oncol. 1999 Jan;17(1):191-6.

PMID:
10458233
3.

Prednisone response is the strongest predictor of treatment outcome in infant acute lymphoblastic leukemia.

Dördelmann M, Reiter A, Borkhardt A, Ludwig WD, Götz N, Viehmann S, Gadner H, Riehm H, Schrappe M.

Blood. 1999 Aug 15;94(4):1209-17.

4.

Cytogenetic studies of infant acute lymphoblastic leukemia: poor prognosis of infants with t(4;11) - a report of the Children's Cancer Group.

Heerema NA, Sather HN, Ge J, Arthur DC, Hilden JM, Trigg ME, Reaman GH.

Leukemia. 1999 May;13(5):679-86.

PMID:
10374870
5.

Treatment outcome and prognostic factors for infants with acute lymphoblastic leukemia treated on two consecutive trials of the Children's Cancer Group.

Reaman GH, Sposto R, Sensel MG, Lange BJ, Feusner JH, Heerema NA, Leonard M, Holmes EJ, Sather HN, Pendergrass TW, Johnstone HS, O'Brien RT, Steinherz PG, Zeltzer PM, Gaynon PS, Trigg ME, Uckun FM.

J Clin Oncol. 1999 Feb;17(2):445-55.

PMID:
10080584
6.

Acute lymphoblastic leukemia in infants.

Pui CH, Evans WE.

J Clin Oncol. 1999 Feb;17(2):438-40. No abstract available.

PMID:
10080582
7.

Intensified therapy for infants with acute lymphoblastic leukemia: results from the Dana-Farber Cancer Institute Consortium.

Silverman LB, McLean TW, Gelber RD, Donnelly MJ, Gilliland DG, Tarbell NJ, Sallan SE.

Cancer. 1997 Dec 15;80(12):2285-95.

PMID:
9404706
8.

Therapeutic trial for infant acute lymphoblastic leukemia: the Pediatric Oncology Group experience (POG 8493).

Frankel LS, Ochs J, Shuster JJ, Dubowy R, Bowman WP, Hockenberry-Eaton M, Borowitz M, Carroll AJ, Steuber CP, Pullen DJ.

J Pediatr Hematol Oncol. 1997 Jan-Feb;19(1):35-42.

PMID:
9065717
9.

Frequency and clinical significance of the MLL gene rearrangements in infant acute leukemia.

Taki T, Ida K, Bessho F, Hanada R, Kikuchi A, Yamamoto K, Sako M, Tsuchida M, Seto M, Ueda R, Hayashi Y.

Leukemia. 1996 Aug;10(8):1303-7.

PMID:
8709635
10.

Prognostic factors in the acute lymphoid and myeloid leukemias of infants.

Pui CH, Ribeiro RC, Campana D, Raimondi SC, Hancock ML, Behm FG, Sandlund JT, Rivera GK, Evans WE, Crist WM, Krance R.

Leukemia. 1996 Jun;10(6):952-6.

PMID:
8667651
11.

Molecular rearrangements on chromosome 11q23 predominate in infant acute lymphoblastic leukemia and are associated with specific biologic variables and poor outcome.

Chen CS, Sorensen PH, Domer PH, Reaman GH, Korsmeyer SJ, Heerema NA, Hammond GD, Kersey JH.

Blood. 1993 May 1;81(9):2386-93.

12.

Heterogeneity in MLL/AF-4 fusion messenger RNA detected by the polymerase chain reaction in t(4;11) acute leukemia.

Hilden JM, Chen CS, Moore R, Frestedt J, Kersey JH.

Cancer Res. 1993 Sep 1;53(17):3853-6.

13.

Improved survival for acute lymphoblastic leukaemia in infancy: the experience of EORTC-Childhood Leukaemia Cooperative Group.

Ferster A, Bertrand Y, Benoit Y, Boilletot A, Behar C, Margueritte G, Thyss A, Robert A, Mazingue F, Souillet G, et al.

Br J Haematol. 1994 Feb;86(2):284-90.

PMID:
8199016
14.

Cytogenetic features of infants less than 12 months of age at diagnosis of acute lymphoblastic leukemia: impact of the 11q23 breakpoint on outcome: a report of the Childrens Cancer Group.

Heerema NA, Arthur DC, Sather H, Albo V, Feusner J, Lange BJ, Steinherz PG, Zeltzer P, Hammond D, Reaman GH.

Blood. 1994 Apr 15;83(8):2274-84.

15.

Frequency and prognostic significance of HRX rearrangements in infant acute lymphoblastic leukemia: a Pediatric Oncology Group study.

Rubnitz JE, Link MP, Shuster JJ, Carroll AJ, Hakami N, Frankel LS, Pullen DJ, Cleary ML.

Blood. 1994 Jul 15;84(2):570-3.

16.

Prognostic relevance of ALL-1 gene rearrangement in infant acute leukemias.

Cimino G, Rapanotti MC, Rivolta A, Lo Coco F, D'Arcangelo E, Rondelli R, Basso G, Barisone E, Rosanda C, Santostasi T, et al.

Leukemia. 1995 Mar;9(3):391-5.

PMID:
7885037
17.

Detection of four different 11q23 chromosomal abnormalities by multiplex-PCR and fluorescence-based automatic DNA-fragment analysis.

Repp R, Borkhardt A, Haupt E, Kreuder J, Brettreich S, Hammermann J, Nishida K, Harbott J, Lampert F.

Leukemia. 1995 Jan;9(1):210-5.

PMID:
7845020
18.

Biology and treatment of infant leukemias.

Pui CH, Kane JR, Crist WM.

Leukemia. 1995 May;9(5):762-9. Review.

PMID:
7769837
19.

Molecular analysis of infant acute lymphoblastic leukemia: MLL gene rearrangement and reverse transcriptase-polymerase chain reaction for t(4; 11)(q21; q23).

Hilden JM, Frestedt JL, Moore RO, Heerema NA, Arthur DC, Reaman GH, Kersey JH.

Blood. 1995 Nov 15;86(10):3876-82.

20.

Estimation of the proportional hazard in two-treatment-group clinical trials.

Bernstein L, Anderson J, Pike MC.

Biometrics. 1981 Sep;37(3):513-9.

PMID:
7317558
Items per page

Supplemental Content

Write to the Help Desk